[music playing]
[NARRATOR] Optum Rx believes that better plan value
begins with care that's grounded in clinical insight
and a deep understanding of human needs.
Our solutions are designed to help your plan
ease the burden of rising drug costs
while also supporting better health outcomes.
Optum Rx makes evidence-based decisions about care
to deliver better health outcomes and total cost savings.
Our combination of data, technology, and clinical expertise
brings lower costs to our highly managed clients
compared to those with fewer pharmacy management programs.
Specialty medications are contributing
to longer and healthier lives,
but they're also some of the biggest pharmacy cost drivers.
Programs like Specialty Standards and Copay Card Solutions
can deliver immediate cost savings on specialty drugs
by providing expert clinical reviews
and making sure your plan
can use all the available manufacturer promotional dollars.
Vigilant Drug List and Premium Formulary
are two more evidence-based programs.
They eliminate wasteful spending
by identifying and avoiding high-cost drugs
that add no clinical value
and have reasonably priced alternatives.
GLP-1s are some of the most talked about drugs.
Sales are projected to reach $150 billion per year by 2030.
That's nearly 20% of the entire US drug market today.
Optum Rx will help you develop a customized GLP-1 approach
that lets you achieve the best clinical benefit
and cost-effectiveness for your members.
Optum Rx is also an industry leader
in integrating cost-effective biosimilars to its formulary.
Our patient first approach focuses on interchangeability,
comparable doses and strengths, and affordability.
Lower drug prices are a good thing,
but an effective drug strategy can also lower your medical costs.
We support members at different stages
of their treatment journey,
whether keeping new patients on track
or guiding those further along
with changes in their health or new treatment options.
For individuals taking multiple medications,
we showcase opportunities
to adjust or stop therapies that may no longer be beneficial.
Getting the most value from expensive therapies
is an excellent way to lower costs
while providing access to these life-changing therapies.
The Orphan Drug Program targets about 40 rare disease drugs
with personalized care management
from an expert clinical pharmacist.
And Optum Rx can help with risk management programs
that can smooth volatile cost spikes and minimize trend
with spending caps and predictable monthly fees.
By grounding every benefit decision on the best clinical guidance,
Optum Rx works to get the right medication
to the right patient, at the right price.
[music fading]